Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Rotselaar – page 159

1 981 clinical trials in Rotselaar, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Rotselaar at a glance
1 981
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 981 trials in Rotselaar

Open in trial search

Cataract

Not recruiting

Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Tropicamide
  • Sponsor:Antwerp University Hospital

Epilepsy

Not recruiting

Study on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Study on the Effects of Adalimumab and Saline in Patients Undergoing Needle Fasciotomy for Dupuytren's Disease

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:UZ Leuven

Ischaemic stroke

Not recruiting

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Insel Gruppe AG

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Onzemipgene parvec
  • Sponsor:Janssen Cilag International

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Volixibat
  • Sponsor:Mirum Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-668
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Open angle glaucoma+2

Not recruiting

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Citicoline Sodium
  • Sponsor:Omikron Italia S.r.l.

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Malignant melanoma

Not recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Factor VIII deficiency+3

Not recruiting

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Sponsor:Apcintex Limited

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Rotselaar

What the registry says about research in the country

01 Gastroenterology Research

Innovative clinical research focusing on proton pump inhibitor (PPI) de-prescribing strategies for patients with chronic usage patterns. This study explores alternative approaches for managing functional dyspepsia and related conditions.

  • Primary Care Management
  • Medication Optimization
  • Digestive Health

The research evaluates the effectiveness of on-demand medication use and alternative treatments, aiming to improve long-term patient care strategies in treating gastric acid-related conditions.

02 Therapeutic Optimization

Investigation into optimal medication reduction strategies, comparing alginate-based therapy with traditional stepping-down approaches. The study addresses common digestive conditions including heartburn and reflux.

  • Treatment Alternatives
  • Patient-Centered Care
  • Medication Management

This research aims to establish evidence-based guidelines for discontinuing long-term acid suppression therapy while maintaining patient comfort and health outcomes.

03 Clinical Care Innovation

Assessment of novel approaches in managing chronic acid reflux conditions, focusing on patient-oriented solutions and sustainable treatment strategies in primary care settings.

  • Quality of Life Improvement
  • Sustainable Healthcare
  • Evidence-Based Practice

The research explores comparative effectiveness of different therapeutic approaches, aiming to optimize long-term patient outcomes in digestive health management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.